Mind Medicine (also often recognized as MindMed) was the primary psychedelic drugmaker to conduct an preliminary public providing (IPO), on Canada’s NEO Exchange in March 2020. The company had been founded less than a yr earlier, in May 2019. The drugmaker is currently conducting two section three research evaluating COMP360 in treatment-resistant melancholy...